Purdue: Amplified Sciences Receives $400,000 NCI Grant to Improve Early Detection of Pancreatic Cancer
July 13, 2023
July 13, 2023
WEST LAFAYETTE, Indiana, July 13 (TNSfund) -- Purdue University issued the following news release:
Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diagnostic test currently in development.
Amplified Sciences, a clinical-stage life sciences diagnostic company that licenses Purdue University innovations, has received a Phase I . . .
Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diagnostic test currently in development.
Amplified Sciences, a clinical-stage life sciences diagnostic company that licenses Purdue University innovations, has received a Phase I . . .